Search - Université de Rennes Access content directly

Filter your results

4 Results
authFullName_s : Anne Thiebaut-Bertrand

Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC

Loic Ysebaert , Roch Houot , Ibrahim Yakoub-Agha , Franck Morschhauser , Charles Herbaux et al.
Blood, 2015, 126 (23), pp.3979-3979
Journal articles hal-01290424v1

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Roch Houot , Tony Marchand , Nathalie Dhédin , Willy Lescaut , Anne Thiebaut-Bertrand et al.
Blood, 2017, 129 (10), pp.1380-1388. ⟨10.1182/blood-2016-09-738385⟩
Journal articles hal-01517054v1

In Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL), Age-Adapted Chemotherapy Intensity and MRD-Driven Transplant Indication Significantly Reduces Treatment-Related Mortality (TRM) and Improves Overall Survival - Results from the Graall-2014 Trial

Nicolas Boissel , Francoise Huguet , Thibaut Leguay , Hunault-Berger Mathilde , Carlos Graux et al.
Blood, 2022, 140 (Supplement 1), pp.112-114. ⟨10.1182/blood-2022-157903⟩
Journal articles hal-04020877v1

Frontline Consolidation with Blinatumomab for High-Risk Philadelphia-Negative Acute Lymphoblastic Adult Patients. Early Results from the Graall-2014-QUEST Phase 2

Nicolas Boissel , Francoise Huguet , Carlos Graux , Yosr Hicheri , Patrice Chevallier et al.
Blood, 2021, 614.Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies, 138 (Supplement 1), pp.1232-1232. ⟨10.1182/blood-2021-146163⟩
Journal articles hal-03789523v1